Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Johnson & Johnson    JNJ

JOHNSON & JOHNSON

(JNJ)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Johnson & Johnson
Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being. The Consumer segment includes a range of products used in the baby care, oral care, skin care, over-the-counter pharmaceutical, women's health and wound care markets. The Pharmaceutical segment is focused on five therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, and cardiovascular and metabolic diseases. The Medical Devices segment includes a range of products used in the orthopedic, surgery, cardiovascular, diabetes care and vision care fields. Its research facilities are located in the United States, Belgium, Brazil, Canada, China, France, Germany, India, Israel, Japan, the Netherlands, Singapore, Switzerland and the United Kingdom.

Number of employees : 132 200 people.
Sales per Business
20182019Delta
USD (in Million)%USD (in Million)%
Pharmaceutical40,73450%42,19851.4% +3.59%
Medical Devices26,99433.1%25,96331.6% -3.82%
Consumer13,85317%13,89816.9% +0.32%
Sales per region
20182019Delta
USD (in Million)%USD (in Million)%
United States41,88451.4%42,09751.3% +0.51%
Europe18,75323%18,46622.5% -1.53%
Asia-Pacific, Africa14,83118.2%15,55518.9% +4.88%
Western Hemisphere Excluding United States6,1137.5%5,9417.2% -2.81%
Managers
NameAgeSinceTitle
Alex Gorsky582012Chairman & Chief Executive Officer
Joseph J. Wolk-2018Chief Financial Officer & Executive Vice President
Paulus Stoffels, Dr.592012Chief Scientific Officer
James D. Swanson-2019Global Chief Information Officer & Executive VP
Charles O. Prince692006Independent Director
Anne M. Mulcahy672012Lead Independent Director
Ronald A. Williams692011Independent Director
Ian Davis672010Independent Director
A. Eugene Washington, Dr.682012Independent Director
Mark B. McClellan, Dr.552013Independent Director
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 3,120,218,672 2,630,358,745 84.3% 487,676,000 15.6% 84.3%
Shareholders
NameEquities%
The Vanguard Group, Inc. 219,272,027 8.33%
SSgA Funds Management, Inc. 149,722,339 5.69%
BlackRock Fund Advisors 64,137,651 2.44%
Putnam LLC 50,777,264 1.93%
Geode Capital Management LLC 39,542,824 1.50%
State Farm Investment Management Corp. 34,574,792 1.31%
Northern Trust Investments, Inc.(Investment Management) 33,972,792 1.29%
Capital Research & Management Co. 32,520,000 1.24%
Massachusetts Financial Services Co. 29,449,490 1.12%
Wellington Management Co. LLP 28,769,995 1.09%
Holdings
NameEquities%Valuation
Adimmune Corporation (4142) 18,715,0004.36%38,145,100 USD
Cryo-Cell International, Inc. (CCEL) 152,7242.02%1,015,615 USD
GRAIL, Inc. 50,868,6717.58%509 USD
Idorsia Ltd (IDIA) 00.0000%
Company contact information
Johnson & Johnson
One Johnson & Johnson Plaza
New Brunswick, NJ 08933

Phone : +1.732.524.0400
Web : http://www.jnj.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of Johnson & Johnson
Sector Pharmaceuticals - NEC
1st jan.Capitalization (M$)
JOHNSON & JOHNSON-1.50%378 244
ROCHE HOLDING AG-4.41%282 585
PFIZER INC.-1.59%203 048
NOVARTIS AG-11.88%202 620
MERCK & CO., INC.-11.97%202 555
ABBVIE INC.17.69%183 962
NOVO NORDISK A/S6.40%152 415
BRISTOL-MYERS SQUIBB COMPANY-2.10%142 003
ASTRAZENECA PLC1.85%137 013
ELI LILLY AND COMPANY10.13%131 228
AMGEN INC.-8.61%128 258
SANOFI-4.74%126 012
GLAXOSMITHKLINE PLC-21.87%91 855
CHUGAI PHARMACEUTICAL CO., LTD.42.95%73 525
JIANGSU HENGRUI MEDICINE CO., LTD.17.92%69 214
DAIICHI SANKYO COMPANY, LIMITED56.60%68 978
BAYER AG-32.50%57 498
TAKEDA PHARMACEUTICAL COMPANY LIMITED-15.03%55 234
ASTELLAS PHARMA INC.-15.08%28 729
HANSOH PHARMACEUTICAL GROUP COMPANY LIMITED36.49%26 384
EISAI CO., LTD.-4.69%21 222